Affiliation:
1. Office of the Executive Vice Chancellor and General Counsel and
2. Department of Pathology and Immunology, Washington University School of Medicine St. Louis, MO
3. BJC HealthCare, St. Louis, MO
Abstract
BACKGROUND
The use of human blood and tissue is critical to biomedical research. A number of treaties, laws, and regulations help to guide the ethical collection of these specimens. However, there are no clearly defined regulations regarding the ownership of human tissue specimens and who can control their fate.
CONTENT
This review discusses the existing regulations governing human studies and the necessary components of patient consent. Legal cases that have addressed the issue of ownership of human tissue are reviewed, including recent settlements that have led to the destruction of millions of specimens of patient tissue. The unique regulations that guide the use of tissues collected postmortem are also examined. Potential changes in the future of biomedical research that uses human tissue, including genetic material, are also discussed.
SUMMARY
The use of human tissue is directed by numerous laws and regulations. Awareness of these rules and of how and when to obtain meaningful informed consent from patients is essential for laboratorians and researchers, who should also be familiar with situations that have led to lawsuits and in some cases the destruction of valuable human tissue specimens.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Reference21 articles.
1. Lessons from history: human anatomy, from the origin to the renaissance;Malomo;Int J Morphol,2006
2. World Medical Association (WMA). WMA Declaration of Helsinki: ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/index.html (Accessed August 2010).
3. US HHS. Code of Federal Regulations. Title 45: Public Welfare. Part 46: Protection of human subjects. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm (Accessed August 2010).
4. US HHS. Code of Federal Regulations. Title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm?CFRPart=50 (Accessed August 2010).
5. One-time general consent for research on biological samples;Wendler;Arch Int Med,2006
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献